Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

Konstantinos KatsanosBenjamin P GeislerAbigail M GarnerHany ZayedTrevor ClevelandJan B Pietzsch

Published in: BMJ open (2016)

Widespread adoption of drug-eluting endovascular therapies for femoropopliteal disease would add meaningful clinical benefit at reasonable additional costs to the NHS. Based on currently available data, DCBs offer the highest clinical and economic value.

Keyphrases

electronic health record
big data
cross sectional
machine learning
aortic dissection
deep learning
artificial intelligence